Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT ?4.1mm RC, SLA? 16mm, TiZr, Loxim: medical device reports filed with FDA

631 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

631
device reports naming the brand
0% of all MAUDE reports · about 92 a year
105
reports, 12 months to August 2026
137 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 631 reports that name the brand "BLT ?4.1mm RC, SLA? 16mm, TiZr, Loxim" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

105 reports arrived in the 12 months to August 2026, down 23% from 137 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (68.1%), loss of osseointegration (23.6%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02039Sep 2021: 4Oct 2021: 5Nov 2021: 12Dec 2021: 132022Jan 2022: 7Feb 2022: 10Mar 2022: 2Apr 2022: 10May 2022: 4Jun 2022: 8Jul 2022: 4Aug 2022: 7Sep 2022: 14Oct 2022: 13Nov 2022: 10Dec 2022: 62023Jan 2023: 5Feb 2023: 6Mar 2023: 11Apr 2023: 10May 2023: 3Jun 2023: 2Jul 2023: 5Aug 2023: 4Sep 2023: 7Oct 2023: 8Nov 2023: 2Dec 2023: 62024Jan 2024: 2Feb 2024: 3Mar 2024: 17Apr 2024: 3May 2024: 3Jun 2024: 3Jul 2024: 3Aug 2024: 13Sep 2024: 8Oct 2024: 13Nov 2024: 12Dec 2024: 122025Jan 2025: 15Feb 2025: 6Mar 2025: 14Apr 2025: 4May 2025: 0Jun 2025: 39Jul 2025: 5Aug 2025: 9Sep 2025: 8Oct 2025: 8Nov 2025: 9Dec 2025: 92026Jan 2026: 7Feb 2026: 8Mar 2026: 12Apr 2026: 8May 2026: 3Jun 2026: 6Jul 2026: 15Aug 2026: 12

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0631262019: 4920192020: 5420202021: 7520212022: 9520222023: 6920232024: 9220242025: 12620252026: 712026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%631
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84.5%533
Voluntary report0%0
User facility report0%0
Distributor report15.5%98
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate43068.1%62.8%
Loss of osseointegration14923.6%22.4%
Difficult to insertthe device was hard to insert30.5%0.4%
Fracturea broken bone20.3%1.6%
Therapeutic or diagnostic output failure20.3%0%
Activation, positioning or separation problem10.2%0%
Unintended movement10.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis22736%
Painpain, site not specified16926.8%
Inflammationinflammation7111.3%
Tissue damage6510.3%
Hemorrhage/blood loss/bleeding579%
Swelling/ edema406.3%
Hyperresponsive to stimuli325.1%
Fistula294.6%
Abscessa collection of pus284.4%
Hypersensitivity/allergic reaction203.2%
Increased sensitivity40.6%
Sinus perforation30.5%
Failure of implant20.3%
Numbnessnumbness20.3%
Inadequate osseointegration10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT ?4.1mm RC, SLA? 16mm, TiZr, LoximProduct code DZEAll MAUDE reports
Reports6313,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT ?4.1mm RC, SLA? 16mm, TiZr, Loxim reports

How many FDA reports name BLT ?4.1mm RC, SLA? 16mm, TiZr, Loxim?

631 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 105 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (68.1%), loss of osseointegration (23.6%), difficult to insert (0.5%), fracture (0.3%) and therapeutic or diagnostic output failure (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84.5%) and distributor reports (15.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT ?4.1mm RC, SLA? 16mm, TiZr, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.